Wikidata

(Q62809021)

English

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

clinical trial

In more languages

Statements

title
A Phase 1b, Open-Label, Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease (English)
0 references
country
Australia
0 references
start time
1 October 2017
0 references
end time
18 April 2018
0 references
number of participants
10
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62809021&oldid=2149175406"